The continued operation of the Canadian national research universal reactor at the Chalk River Laboratories in Ontario rests on its ability to deliver economic and scientific benefits once it halts production of medical isotopes in 2016, said Robert Walker, president and CEO of Atomic Energy of Canada. The Canadian government is also looking into the possibilities of replacing the reactor with a new Canadian research reactor and reorganizing Atomic Energy of Canada into a government-owned contractor-operated partnership next year.

Related Summaries